Lund SS - Search Results

1

The effect of sodium glucose cotransporter 2 inhibition with empagliflozin on microalbuminuria and macroalbuminuria in patients with type 2 diabetes.

Cherney D, Lund SS, Perkins BA, Groop PH, Cooper ME, Kaspers S, Pfarr E, Woerle HJ, von Eynatten M. Cherney D, et al. Among authors: lund ss. Diabetologia. 2016 Sep;59(9):1860-70. doi: 10.1007/s00125-016-4008-2. Epub 2016 Jun 17. Diabetologia. 2016. PMID: 27316632 Clinical Trial.

2

Pharmacodynamic Effects of Single and Multiple Doses of Empagliflozin in Patients With Type 2 Diabetes.

Heise T, Jordan J, Wanner C, Heer M, Macha S, Mattheus M, Lund SS, Woerle HJ, Broedl UC. Heise T, et al. Among authors: lund ss. Clin Ther. 2016 Oct;38(10):2265-2276. doi: 10.1016/j.clinthera.2016.09.001. Epub 2016 Sep 28. Clin Ther. 2016. PMID: 27692976 Clinical Trial.

3

Pooled analysis of Phase III trials indicate contrasting influences of renal function on blood pressure, body weight, and HbA1c reductions with empagliflozin.

Cherney DZI, Cooper ME, Tikkanen I, Pfarr E, Johansen OE, Woerle HJ, Broedl UC, Lund SS. Cherney DZI, et al. Among authors: lund ss. Kidney Int. 2018 Jan;93(1):231-244. doi: 10.1016/j.kint.2017.06.017. Epub 2017 Aug 30. Kidney Int. 2018. PMID: 28860019 Free article.

4

Empagliflozin reduces body weight and indices of adipose distribution in patients with type 2 diabetes mellitus.

Neeland IJ, McGuire DK, Chilton R, Crowe S, Lund SS, Woerle HJ, Broedl UC, Johansen OE. Neeland IJ, et al. Among authors: lund ss. Diab Vasc Dis Res. 2016 Mar;13(2):119-26. doi: 10.1177/1479164115616901. Diab Vasc Dis Res. 2016. PMID: 26873905 Free PMC article. Clinical Trial.

5

Acute Pharmacodynamic Effects of Empagliflozin With and Without Diuretic Agents in Patients With Type 2 Diabetes Mellitus.

Heise T, Jordan J, Wanner C, Heer M, Macha S, Mattheus M, Lund SS, Woerle HJ, Broedl UC. Heise T, et al. Among authors: lund ss. Clin Ther. 2016 Oct;38(10):2248-2264.e5. doi: 10.1016/j.clinthera.2016.08.008. Epub 2016 Sep 22. Clin Ther. 2016. PMID: 27666126 Clinical Trial.

6

The effect of empagliflozin on muscle sympathetic nerve activity in patients with type II diabetes mellitus.

Jordan J, Tank J, Heusser K, Heise T, Wanner C, Heer M, Macha S, Mattheus M, Lund SS, Woerle HJ, Broedl UC. Jordan J, et al. Among authors: lund ss. J Am Soc Hypertens. 2017 Sep;11(9):604-612. doi: 10.1016/j.jash.2017.07.005. Epub 2017 Jul 21. J Am Soc Hypertens. 2017. PMID: 28757109 Clinical Trial.

7

Effect of Empagliflozin on Free Fatty Acids and Ketone Bodies in Japanese Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial.

Nishimura R, Tanaka Y, Koiwai K, Ishida K, Salsali A, Kaspers S, Kohler S, Lund SS. Nishimura R, et al. Among authors: lund ss. Adv Ther. 2019 Oct;36(10):2769-2782. doi: 10.1007/s12325-019-01045-x. Epub 2019 Aug 23. Adv Ther. 2019. PMID: 31444706 Clinical Trial.

8

Effects of empagliflozin on first and recurrent clinical events in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a secondary analysis of the EMPA-REG OUTCOME trial.

McGuire DK, Zinman B, Inzucchi SE, Wanner C, Fitchett D, Anker SD, Pocock S, Kaspers S, George JT, von Eynatten M, Johansen OE, Jamal W, Mattheus M, Elsasser U, Hantel S, Lund SS. McGuire DK, et al. Among authors: lund ss. Lancet Diabetes Endocrinol. 2020 Dec;8(12):949-959. doi: 10.1016/S2213-8587(20)30344-2. Lancet Diabetes Endocrinol. 2020. PMID: 33217335 Clinical Trial.

9

Cardiovascular Safety of Empagliflozin Versus Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in Type 2 Diabetes: Systematic Literature Review and Indirect Comparisons.

Balijepalli C, Shirali R, Kandaswamy P, Ustyugova A, Pfarr E, Lund SS, Druyts E. Balijepalli C, et al. Among authors: lund ss. Diabetes Ther. 2018 Aug;9(4):1491-1500. doi: 10.1007/s13300-018-0456-7. Epub 2018 Jun 12. Diabetes Ther. 2018. PMID: 29949014 Free PMC article.

10

Correction to: Cardiovascular Safety of Empagliflozin Versus Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in Type 2 Diabetes: Systematic Literature Review and Indirect Comparisons.

Balijepalli C, Shirali R, Kandaswamy P, Ustyugova A, Pfarr E, Lund SS, Druyts E. Balijepalli C, et al. Among authors: lund ss. Diabetes Ther. 2019 Feb;10(1):325-326. doi: 10.1007/s13300-018-0543-9. Diabetes Ther. 2019. PMID: 30519858 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters